nach oben

Current Bladder Dysfunction Reports

Erschienen in:

01.09.2014 | Pediatric Bladder Dysfunction (SJ Hodges, Section Editor)

The Role of Bladder and Bowel Dysfunction (BBD) in Pediatric Urinary Tract Infections

verfasst von: Linda C. Lee, Martin A. Koyle

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

The child with lower urinary tract symptoms, in the absence of neurological abnormalities, represents an increasingly common source of referral to the pediatric urologist. Patients with lower urinary tract dysfunction are at increased risk of urinary tract infections (UTIs), which can be a potential source of expense, inconvenience, and even morbidity and renal impairment. Many of these patients present with concomitant bowel dysfunction in the form of constipation and encopresis. As a result, the term “bladder and bowel dysfunction” (BBD) has been introduced and refers to the close relationship of the bladder and bowel and their interrelated disturbances. An in-depth understanding of BBD and its role in recurrent UTI is the key to treatment and prevention of further morbidity in these patients. We present an updated review of the literature on BBD and UTIs in children, including its pathogenesis, evaluation, and management.

Hinman F. Nonneurogenic neurogenic bladder (the Hinman syndrome)—15 years later. J Urol. 1986;136:769–77.PubMed

Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol. 1998;160:1019–22.PubMedCrossRef

3.••

Austin PF et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the Standardization Committee of the International Children’s Continence Society. J Urol. 2014. doi:10.1016/j.juro.2014.01.110. Author's Note: Consistent use of terminology is important for future research and clinical practice. As such, it is crucial that pediatric urologists are familiar with this report.PubMedCentral

Nevéus T et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children’s Continence Society. J Urol. 2006;176:314–24.PubMedCrossRef

Yoshimura N, Chancellor MB. “Chapter 60: Physiology and Pharmacology of the Bladder and Urethra.” In: Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. 10th ed. Philadelphia: Elsevier Saunders; 2012. p. 1786–833.

Yeung C, Barker GM and Lackgren G. “Chapter 17: Pathophysiology of Bladder Dysfunction.” In: Gearhart J, Rink R, Mouriquand P, editors. Pediatric Urology. 2nd ed. Philadelphia: Elsevier Saunders; 2010. p. 353–65.

Burgers R et al. Functional defecation disorders in children with lower urinary tract symptoms. J Urol. 2013;189:1886–91.PubMedCrossRef

Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics. 1997;100:228–32.PubMedCrossRef

Burgers R et al. Effect of rectal distention on lower urinary tract function in children. J Urol. 2010;184:1680–5.PubMedCrossRef

10.

O’Regan S, Yazbeck S, Schick E. Constipation, bladder instability, urinary tract infection syndrome. Clin Nephrol. 1985;23:152–4.PubMed

11.

Wald A, Chandra R, Chiponis D, Gabel S. Anorectal function and continence mechanisms in childhood encopresis. J Pediatr Gastroenterol Nutr. 1986;5:346–51.PubMedCrossRef

12.

Heyns CF. Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder. World J Urol. 2011;30:77–83.PubMedCrossRef

13.

Hellström A, Hanson E, Hansson S, Hjälmås K, Jodal U. Association between urinary symptoms at 7 years old and previous urinary tract infection. Arch Dis Child. 1991;66:232–4.PubMedCentralPubMedCrossRef

14.

Van Batavia JP, Ahn JJ, Fast AM, Combs AJ, Glassberg KI. Prevalence of urinary tract infection and vesicoureteral reflux in children with lower urinary tract dysfunction. J Urol. 2013;190:1495–500.PubMedCrossRef

15.

Chen JJ, Mao W, Homayoon K, Steinhardt GF. A multivariate analysis of dysfunctional elimination syndrome, and its relationships with gender, urinary tract infection and vesicoureteral reflux in children. J Urol. 2004;171:1907–10.PubMedCrossRef

16.

Shaikh N et al. Dysfunctional elimination syndrome: is it related to urinary tract infection or vesicoureteral reflux diagnosed early in life? Pediatrics. 2003;112:1134–7.PubMedCrossRef

17.

Peters CA et al. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J Urol. 2010;184:1134–44.PubMedCrossRef

18.

Zink S, Freitag CM, von Gontard A. Behavioral comorbidity differs in subtypes of enuresis and urinary incontinence. J Urol. 2008;179:295–8.PubMedCrossRef

19.

Mazzola BL, Von Vigier RO, Marchand S, Tonz M, Blanchetti MG. Behavioral and functional abnormalities linked to recurrent urinary tract infections in girls. J Nephrol. 2003;16:133–6.PubMed

20.

Von Gontard A, Baeyens D, Van Hoecke E, Warzak WJ, Bachmann C. Psychological and psychiatric issues in urinary and fecal incontinence. J Urol. 2011;185:1432–7.CrossRef

21.••

Burgers RE et al. Management of functional constipation in children with lower urinary tract symptoms: report from the Standardization Committee of the International Children’s Continence Society. J Urol. 2013;190:29–36. Author’s Note: This an excellent reference for those who are evaluating and treating constipation and/or encopresis.PubMedCrossRef

22.

Farhat W et al. The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol. 2000;164:1011–5.PubMedCrossRef

23.

Farhat W, McLorie G, O’Reilly S, Khoury A, Bagli D. Reliability of the pediatric dysfunctional voiding symptom score in monitoring response to behavioral modification. Can J Urol. 2001;8:1401–5.PubMed

24.

Heaton KW et al. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut. 1992;33:818–24.PubMedCentralPubMedCrossRef

25.

Glassberg KI, Combs AJ, Horowitz M. Nonneurogenic voiding disorders in children and adolescents: clinical and videourodynamic findings in 4 specific conditions. J Urol. 2010;184:2123–7.PubMedCrossRef

26.

Joensson IM, Siggaard C, Rittig S, Hagstroem S, Djurhuus JC. Transabdominal ultrasound of rectum as a diagnostic tool in childhood constipation. J Urol. 2008;179:1997–2002.PubMedCrossRef

27.

Tarcan T et al. The value of sacral skin lesions in predicting occult spinal dysraphism in children with voiding dysfunction and normal neurological examination. J Pediatr Urol. 2012;8:55–8.PubMedCrossRef

28.

Lavallée LT, Leonard MP, Dubois C, Guerra LA. Urodynamic testing—is it a useful tool in the management of children with cutaneous stigmata of occult spinal dysraphism? J Urol. 2013;189:678–83.PubMedCrossRef

29.

Jepson RG, Williams G, Craig JC. in Cochrane Database Syst. Rev. (The Cochrane Collaboration & Jepson, R. G.). John Wiley & Sons, Ltd; 2012. doi: 10.1002/14651858.CD001321.pub5

30.

Grin P, Kowalewska P, Alhazzan W, Fox-Robichaud A. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can J Urol. 2013;20:6607–14.PubMed

31.

Mugie SM, Di Lorenzo C, Benninga MA. Constipation in childhood. Nat Rev Gastroenterol Hepatol. 2011;8:502–11.PubMedCrossRef

32.

Bekkali N-L-H et al. Rectal fecal impaction treatment in childhood constipation: enemas versus high doses oral PEG. Pediatrics. 2009;124:e1108–15.PubMedCrossRef

33.

Lee-Robichaud H, Thomas K, Morgan J, Nelson RL. in Cochrane Database Syst. Rev. (The Cochrane Collaboration). John Wiley & Sons, Ltd; 2010. doi. 10.1002/14651858.CD007570.pub2

34.

Vasconcelos M et al. Voiding dysfunction in children. Pelvic-floor exercises or biofeedback therapy: a randomized study. Pediatr Nephrol. 2006;21:1858–64.PubMedCrossRef

35.•

Desantis DJ, Leonard MP, Preston MA, Barrowman NJ, Guerra LA. Effectiveness of biofeedback for dysfunctional elimination syndrome in pediatrics: a systematic review. J Pediatr Urol. 2011;7:342–8. Author’s note: This paper provides a systematic review of biofeedback as a non-invasive therapy for BBD. Nevertheless, the authors acknowledge the need for RCTs and better quality research on this topic.PubMedCrossRef

36.

Austin PF. The role of alpha blockers in children with dysfunctional voiding. Sci World J. 2009;9:880–3.CrossRef

37.

Austin P et al. Alpha-adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction. J Urol. 1999;162:1064–7.PubMedCrossRef

38.

Cain M, Wu S, Austin P, Herndon C, Rink R. Alpha blocker therapy for children with dysfunctional voiding and urinary retention. J Urol. 2003;170:1514–5.PubMedCrossRef

39.

Donohoe JM, Combs AJ, Glassberg KI. Primary bladder neck dysfunction in children and adolescents II: results of treatment with α-adrenergic antagonists. J Urol. 2005;173:212–6.PubMedCrossRef

40.

Kramer S, Rathbun S, Elkins D, Karnes R, Husmann D. Double-blind placebo controlled study of α-adrenergic receptor antagonists (DOXAZOSIN) for treatment of voiding dysfunction in the pediatric population. J Urol. 2005;173:2121–4.PubMedCrossRef

41.

Yucel S et al. Can alpha-blocker therapy be an alternative to biofeedback for dysfunctional voiding and urinary retention? A prospective study. J Urol. 2005;174:1612–5.PubMedCrossRef

42.

Goessl C et al. Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia. Urology. 2000;55:414–8.PubMedCrossRef

43.

Hjälmås K, Hellström A-L, Mogren K, Läckgren G, Stenberg A. The overactive bladder in children: a potential future indication for tolterodine. BJU Int. 2001;87:569–74.PubMedCrossRef

44.

Raes A et al. Retrospective analysis of efficacy and tolerability of tolterodine in children with overactive bladder. Eur Urol. 2004;45:240–4.PubMedCrossRef

45.

Ayan S et al. Efficacy of tolterodine as a first-line treatment for non-neurogenic voiding dysfunction in children. BJU Int. 2005;96:411–4.PubMedCrossRef

46.

Kilic N, Balkan E, Akgoz S, Sen N, Dogruyol H. Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability. Int J Urol. 2006;13:105–8.PubMed

47.

Bolduc S et al. The use of tolterodine in children after oxybutynin failure. BJU Int. 2003;91:398–401.PubMedCrossRef

48.

Mungding M, Wessells H, Thornberry B, Riden D. Use of tolterodine in children with dysfunctional voiding: an initial report. J Urol. 2001;165:926–8.CrossRef

49.

Babu R. Effectiveness of tolterodine in non-neurogenic voiding dysfunction. Indian Pediatr. 2006;43:980.PubMed

50.

Ayan S, Topsakal K, Gokce G, Gultekin EY. Efficacy of combined anticholinergic treatment and behavioral modification as a first line treatment for nonneurogenic and nonanatomical voiding dysfunction in children: a randomized controlled trial. J Urol. 2007;177:2325–9.PubMedCrossRef

51.

Mangera A et al. An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders. Eur Urol. 2014;65:981–90.PubMedCrossRef

52.

Steinhardt GF, Naseer S, Cruz OA. Botulinum toxin: novel treatment for dramatic urethral dilatation associated with dysfunctional voiding. J Urol. 1997;158:190–1.PubMedCrossRef

53.

Radojicic ZI, Perovic SV, Milic NM. Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin? J Urol. 2006;176:332–6.PubMedCrossRef

54.

Vricella GJ, Campigotto M, Coplen DE, Traxel EJ, Austin PF. Long-term efficacy and durability of botulinum-A toxin for refractory dysfunctional voiding in children. J Urol. 2014. doi:10.1016/j.juro.2013.10.034.PubMed

55.

Franco I, Landau-Dyer L, Isom-Batz G, Collett T, Reda EF. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children. J Urol. 2007;178:1775–80.PubMedCrossRef

56.

Pohl HG et al. The outcome of voiding dysfunction managed with clean intermittent catheterization in neurologically and anatomically normal children. BJU Int. 2002;89:923–7.PubMedCrossRef

57.

Silay MS et al. Twelve-year experience with Hinman-Allen syndrome at a single center. Urology. 2011;78:1397–401.PubMedCrossRef

58.

Handel LN, Barqawi A, Checa G, Furness III PD, Koyle MA. Males with Down’s syndrome and nonneurogenic neurogenic bladder. J. Urol. 2003; 169:646–649.

59.

Griffiths DM, Malone PS. The Malone antegrade continence enema. J Pediatr Surg. 1995;30:68–71.PubMedCrossRef

60.

Chait P, Shandling B, Richards H, Connolly B. Fecal incontinence in children: treatment with percutaneous cecostomy tube placement—a prospective study. Radiology. 1997;203:621–4.PubMedCrossRef

61.

Christison-Lagay ER et al. Antegrade colonic enemas and intestinal diversion are highly effective in the management of children with intractable constipation. J Pediatr Surg. 2010;45:213–9.PubMedCrossRef

62.

Vesna ZD, Milica L, Stanković I, Marina V, Andjelka S. The evaluation of combined standard urotherapy, abdominal and pelvic floor retraining in children with dysfunctional voiding. J Pediatr Urol. 2011;7:336–41.PubMedCrossRef

63.

Yang SS-D, Chiang I-N, Lin C-D, Chang S-J. Advances in non-surgical treatments for urinary tract infections in children. World J Urol. 2011;30:69–75.PubMedCrossRef

64.

Rasquin A et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006;130:1527–37.PubMedCrossRef

Titel: The Role of Bladder and Bowel Dysfunction (BBD) in Pediatric Urinary Tract Infections
verfasst von: Linda C. Lee
Martin A. Koyle
Publikationsdatum: 01.09.2014
Verlag: Springer US
Erschienen in: Current Bladder Dysfunction Reports / Ausgabe 3/2014
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-014-0240-0

Neu im Fachgebiet Urologie

24.04.2024 | DGIM 2024 | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The Role of Bladder and Bowel Dysfunction (BBD) in Pediatric Urinary Tract Infections

Abstract

Neu im Fachgebiet Urologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Update Urologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

Underactive Bladder and Detrusor Underactivity: a Review of Pathophysiology and Management Strategies for This Poorly Understood Bladder Syndrome

Epidemiology, Evaluation, and Treatment of Urinary Incontinence in Octogenarian Women

Update on Overactive Bladder in Children—Current Bladder Dysfunction Reports 2012, 7:27–32

Diabetes and Its Effect on Lower Urinary Tract Function: Pathophysiology and Management

Role of Bladder Dysfunction in Vesicoureteral Reflux

Diagnosis and Management of Fungal Urinary Tract Infections

Neu im Fachgebiet Urologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Update Urologie